Youngbo Chemical영보화학
014440 · KOSPI · ₩014440 · 영보화학
₩4,740▼ ₩10 (0.21%)End-of-day · Oct 27, 2026 · End-of-day prices.
Income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | ₩120B | ₩118B | ₩90B | ₩83B | ₩100B |
| Cost of sales | ₩83B | ₩82B | ₩67B | ₩63B | ₩75B |
| Gross profit | ₩37B | ₩36B | ₩23B | ₩20B | ₩24B |
| Operating income | ₩19B | ₩19B | ₩7B | ₩5B | ₩5.9B |
| Net income | ₩17B | ₩23B | ₩6B | ₩6.7B | ₩3.5B |
| Net income to shareholders | ₩17B | ₩23B | ₩6B | ₩6.7B | ₩3.5B |
Balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Total assets | ₩211B | ₩203B | ₩179B | ₩180B | ₩180B |
| Current assets | ₩106B | ₩100B | ₩79B | ₩76B | ₩76B |
| Cash and equivalents | ₩7.8B | ₩14B | ₩36B | ₩39B | ₩36B |
| Total liabilities | ₩19B | ₩20B | ₩15B | ₩22B | ₩25B |
| Current liabilities | ₩19B | ₩19B | ₩15B | ₩22B | ₩25B |
| Borrowings | ₩0 | ₩0 | ₩2.1B | ₩9.6B | ₩8.7B |
| Total equity | ₩191B | ₩183B | ₩164B | ₩158B | ₩155B |
| Shareholders' equity | ₩191B | ₩183B | ₩164B | ₩158B | ₩155B |
Cash flow
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Cash from operations | ₩15B | ₩21B | ₩16B | ₩10B | ₩17B |
| Capital spending | ₩7.5B | ₩7.1B | ₩5.6B | ₩12B | ₩7.4B |
| Free cash flow | ₩7.9B | ₩14B | ₩11B | −₩1.6B | ₩9.5B |
| Dividends paid | ₩6.8B | ₩975M | ₩975M | ₩2B | ₩1.5B |
Consolidated where available. Amounts in won.
Also known as: Youngbo Chemical / 영보화학 / 014440 / KRX:014440
Source: KRX statistical information